Acropolis Investment Management, LLC - AMGEN INC ownership

AMGEN INC's ticker is and the CUSIP is 31162100. A total of 54 filers reported holding AMGEN INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Acropolis Investment Management, LLC ownership history of AMGEN INC
ValueSharesWeighting
Q1 2015$105,000
-99.9%
6550.0%0.02%0.0%
Q4 2014$104,335,000
+63909.2%
655
-52.5%
0.02%
-39.4%
Q2 2014$163,000
-99.9%
1,380
-33.7%
0.03%
-36.5%
Q1 2014$256,547,000
+15746.0%
2,080
-85.3%
0.05%
-85.1%
Q4 2013$1,619,000
-99.9%
14,193
-5.5%
0.35%
-0.3%
Q3 2013$1,680,666,000
+8.3%
15,016
-4.5%
0.35%
+4.5%
Q2 2013$1,552,020,00015,7310.34%
Other shareholders
AMGEN INC shareholders Q2 2013
NameSharesValueWeighting ↓
Smead Capital Management, Inc. 367,566$51,628,0005.57%
GROESBECK INVESTMENT MANAGEMENT CORP /NJ/ 39,230$5,510,0002.62%
VALLEY WEALTH MANAGERS, INC. 93,378$13,116,0002.51%
Randolph Co Inc 84,100$11,813,0002.44%
Forester Capital Management, LTD 22,060$3,099,0002.42%
Saturna Capital CORP 547,884$76,956,0002.06%
Kiwi Wealth Investments Limited Partnership 135,833$19,079,0001.79%
Dana Investment Advisors, Inc. 209,984$29,494,0001.71%
FULTON BREAKEFIELD BROENNIMAN LLC 40,747$5,723,0001.34%
Eagle Capital Management, LLC 23,004$3,231,0001.23%
View complete list of AMGEN INC shareholders